Drug Type Recombinant polypeptide |
Synonyms |
Target |
Mechanism NPRL2 modulators(NPR2 like, GATOR1 complex subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Immunoforge Co. Ltd.Startup |
Active Organization Immunoforge Co. Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypochondroplasia | Preclinical | KR | Immunoforge Co. Ltd.Startup | 06 May 2024 |